Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 309

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 309
---
 will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment. However, unlike the Series A Warrants and Series C Warrants, the warrants issued on January 6, 2025 are not subject to any exercise price reduction or adjustment relating to the timing of stockholder approval thereof or the pricing of any future offering. Warrants Issued on February 7, 2025 On February 7, 2025, we issued and sold 15,000 shares of our Common Stock and 112,551 February 2025 Pre-Funded Warrants to purchase 112,551 shares of our Common Stock together with 127,551 February 2025 Common Warrants to purchase 127,551 shares of Common Stock. Each share of Common Stock or February 2025 Pre-Funded Warrant was sold together with a February 2025 Common Warrant to purchase one share of Common Stock. The shares of Common Stock or February 2025 Pre-Funded Warrants and accompanying February 2025 Common Warrants were issued separately and were immediately separable upon. February 2025 Pre-Funded Warrants The following summary of certain terms and provisions of the February 2025 Pre-Funded Warrants is not complete and is subject to, and qualified in its entirety by, the provisions of the February 2025 Pre-Funded Warrant, the form of which is filed as Exhibit No. 4.8 to the registration statement filed with the SEC on February 5, 2025. Prospective investors should carefully review the terms and provisions of the form of February 2025 Pre-Funded Warrant for a complete description of the terms and conditions of the February 2025 Pre-Funded Warrants. Duration and Exercise Price.Each February 2025 Pre-Funded Warrant offered has an initial exercise price per share equal to $0.002. The February 2025 Pre-Funded Warrants are immediately exercisable and may be exercised at any time until the February 2025 Pre-Funded Warrants are exercised in full. The exercise price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our Common Stock and the exercise price. Exercisability.Each February 2025 Pre-Funded Warrant may be exercised at any time following the date of issuance and from time to time thereafter until the February 2025 Pre-Funded Warrants